BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Drijvers JM, Sharpe AH, Haigis MC. The effects of age and systemic metabolism on anti-tumor T cell responses. Elife 2020;9:e62420. [PMID: 33170123 DOI: 10.7554/eLife.62420] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
Number Citing Articles
1 Lansdorp PM. Telomeres, aging, and cancer: the big picture. Blood 2022;139:813-21. [PMID: 35142846 DOI: 10.1182/blood.2021014299] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
2 Traba J, Sack MN, Waldmann TA, Anton OM. Immunometabolism at the Nexus of Cancer Therapeutic Efficacy and Resistance. Front Immunol 2021;12:657293. [PMID: 34079545 DOI: 10.3389/fimmu.2021.657293] [Reference Citation Analysis]
3 Huang ZL, Xu B, Li TT, Xu YH, Huang XY, Huang XY. Integrative Analysis Identifies Cell-Type-Specific Genes Within Tumor Microenvironment as Prognostic Indicators in Hepatocellular Carcinoma. Front Oncol 2022;12:878923. [PMID: 35707353 DOI: 10.3389/fonc.2022.878923] [Reference Citation Analysis]
4 Collet L, Delrieu L, Bouhamama A, Crochet H, Swalduz A, Nerot A, Marchal T, Chabaud S, Heudel PE. Association between Body Mass Index and Survival Outcome in Metastatic Cancer Patients Treated by Immunotherapy: Analysis of a French Retrospective Cohort. Cancers (Basel) 2021;13:2200. [PMID: 34063692 DOI: 10.3390/cancers13092200] [Reference Citation Analysis]
5 Jensen AWP, Carnaz Simões AM, Thor Straten P, Holmen Olofsson G. Adrenergic Signaling in Immunotherapy of Cancer: Friend or Foe? Cancers (Basel) 2021;13:394. [PMID: 33494360 DOI: 10.3390/cancers13030394] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Zhang H, Yao Y, Wu J, Zhou J, Zhao C, He J, Xu B. Comprehensive Analysis Identifies and Validates the Tumor Microenvironment Subtypes to Predict Anti-Tumor Therapy Efficacy in Hepatocellular Carcinoma. Front Immunol 2022;13:838374. [DOI: 10.3389/fimmu.2022.838374] [Reference Citation Analysis]
7 Ligotti ME, Aiello A, Accardi G, Aprile S, Bonura F, Bulati M, Gervasi F, Giammanco GM, Pojero F, Zareian N, Caruso C, Farzaneh F, Candore G. Analysis of T and NK cell subsets in the Sicilian population from young to supercentenarian: The role of age and gender. Clin Exp Immunol 2021;205:198-212. [PMID: 33866541 DOI: 10.1111/cei.13606] [Reference Citation Analysis]
8 Howard FHN, Kwan A, Winder N, Mughal A, Collado-Rojas C, Muthana M. Understanding Immune Responses to Viruses-Do Underlying Th1/Th2 Cell Biases Predict Outcome? Viruses 2022;14:1493. [PMID: 35891472 DOI: 10.3390/v14071493] [Reference Citation Analysis]
9 Wallace K, Nahhas GJ, Bookhout C, Lewin DN, Paulos CM, Nikolaishvili-Feinberg N, Cohen SM, Guglietta S, Bakhtiari A, Camp ER, Hill EG, Baron JA, Wu JD, Alekseyenko AV. Preinvasive Colorectal Lesions of African Americans Display an Immunosuppressive Signature Compared to Caucasian Americans. Front Oncol 2021;11:659036. [PMID: 33987094 DOI: 10.3389/fonc.2021.659036] [Reference Citation Analysis]
10 Monferrer E, Vieco-Martí I, López-Carrasco A, Fariñas F, Abanades S, de la Cruz-Merino L, Noguera R, Álvaro Naranjo T. Metabolic Classification and Intervention Opportunities for Tumor Energy Dysfunction. Metabolites 2021;11:264. [PMID: 33922558 DOI: 10.3390/metabo11050264] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Li X, Zhang W, Li M, Wang J, Lian J, Zhou H, Zhang Z. Effectiveness and Safety of PD-1 Inhibitor Monotherapy for Elderly Patients with Advanced Non-Small Cell Lung Cancer: A Real-World Exploratory Study. Journal of Oncology 2022;2022:1-10. [DOI: 10.1155/2022/1710272] [Reference Citation Analysis]